CENTRAL PHARMA CONTRACT HOLDINGS LIMITED

08126719
Active Bedford

Activities of other holding companies n.e.c.

227 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.
C

CENTRAL PHARMA CONTRACT HOLDINGS LIMITED

08126719

Activities of other holding companies n.e.c.

Founded 2 Jul 2012 Active Bedford, United Kingdom 227 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.
Accounts Submitted 30 Sept 2025 Next due 30 Sept 2026 2 months remaining
Confirmation Submitted 3 Mar 2026 Next due 18 Jan 2027 6 months remaining
Net assets £-2M £41K 2024 year on year
Total assets £8M £2M 2024 year on year
Total Liabilities £10M £2M 2024 year on year
Charges 3
2 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

Central Pharma Caxton Road Elm Farm Industrial Estate Bedford MK41 0HT

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CENTRAL PHARMA CONTRACT HOLDINGS LIMITED (08126719), an active life sciences and medical technology company based in Bedford, United Kingdom. Incorporated 2 Jul 2012. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type group
Next accounts 31 Dec 2025
Due by 30 Sept 2026 2 months remaining

Balance Sheet & P&L (2014–2024)

Cash in Bank

£435.00

Decreased by £3.00 (-1%)

Net Assets

-£1.97M

Decreased by £40.61k (-2%)

Total Liabilities

£9.84M

Decreased by £2.26M (-19%)

Turnover

£19.07M

Decreased by £20.94k (-0%)

Employees

227

Increased by 8 (+4%)

Debt Ratio

125%

Increased by 6 (+5%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 170,861 Shares £2.11m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
28 Dec 2022131,985£1.63m£12.347
12 Jun 202038,875£480k£12.347
31 Jul 20131£1£1

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (7)

Verbena Ventures Limited
49.7%
140,159
Michael James Blood
29.7%
83,864

Persons with Significant Control

Persons with Significant Control (3)

3 Active 1 Ceased

Mr Michael James Blood

British

Active
Notified 31 Aug 2018
Residence England
DOB August 1968
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Alwyn Jacobus Smit

South African

Active
Notified 6 Apr 2016
Residence Switzerland
DOB January 1961
Nature of Control
  • Ownership Of Shares 25 To 50 Percent As Trust,voting Rights 25 To 50 Percent As Trust

Mr Alwyn Jacobus Nicolaas Smit

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB January 1961
Nature of Control
  • Ownership Of Shares 50 To 75 Percent
  • Voting Rights 50 To 75 Percent

Ronald Michael Hene

Ceased 31 Aug 2018

Ceased

Group Structure

Group Structure

CENTRAL PHARMA CONTRACT HOLDINGS LIMITED Current Company

Charges

Charges

2 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Jun 2026Persons With Significant ControlChange to Mr Alwyn Jacobus Nicolaas Smit as a person with significant control on 27 Mar 2026
3 Mar 2026Confirmation StatementConfirmation statement made on 4 Jan 2026 with no updates
2 Mar 2026OfficersChange to director Mr Jonathan Derry-Evans on 2 Mar 2026
5 Jan 2026Persons With Significant ControlChange to Mr Alwyn Jacobus Smit as a person with significant control on 1 Jan 2026
31 Dec 2025OfficersTermination of Karen Yvonne Nichol as director on 31 Dec 2025
30 Jun 2026 Persons With Significant Control

Change to Mr Alwyn Jacobus Nicolaas Smit as a person with significant control on 27 Mar 2026

3 Mar 2026 Confirmation Statement

Confirmation statement made on 4 Jan 2026 with no updates

2 Mar 2026 Officers

Change to director Mr Jonathan Derry-Evans on 2 Mar 2026

5 Jan 2026 Persons With Significant Control

Change to Mr Alwyn Jacobus Smit as a person with significant control on 1 Jan 2026

31 Dec 2025 Officers

Termination of Karen Yvonne Nichol as director on 31 Dec 2025

Recent Activity

Latest Activity

Change to Mr Alwyn Jacobus Nicolaas Smit as a person with significant control on 27 Mar 2026

2 days ago on 30 Jun 2026

Confirmation statement made on 4 Jan 2026 with no updates

4 months ago on 3 Mar 2026

Change to director Mr Jonathan Derry-Evans on 2 Mar 2026

4 months ago on 2 Mar 2026

Change to Mr Alwyn Jacobus Smit as a person with significant control on 1 Jan 2026

5 months ago on 5 Jan 2026

Termination of Karen Yvonne Nichol as director on 31 Dec 2025

6 months ago on 31 Dec 2025